• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differences in Cardiac Mechanics and Exercise Physiology Among Heart Failure With Preserved Ejection Fraction Phenomapping Subgroups.射血分数保留心力衰竭表型亚组中心脏力学和运动生理学的差异。
Am J Cardiol. 2023 Apr 15;193:102-110. doi: 10.1016/j.amjcard.2022.12.027. Epub 2023 Mar 7.
2
Heart failure with preserved ejection fraction phenogroup classification using machine learning.采用机器学习对射血分数保留型心力衰竭进行表型分组分类。
ESC Heart Fail. 2023 Jun;10(3):2019-2030. doi: 10.1002/ehf2.14368. Epub 2023 Apr 12.
3
Differences in Repolarization Heterogeneity Among Heart Failure With Preserved Ejection Fraction Phenotypic Subgroups.射血分数保留的心力衰竭表型亚组间复极异质性的差异。
Am J Cardiol. 2017 Aug 15;120(4):601-606. doi: 10.1016/j.amjcard.2017.05.031. Epub 2017 May 30.
4
Clinical and prognostic implications of phenomapping in patients with heart failure receiving cardiac resynchronization therapy.心力衰竭接受心脏再同步治疗患者表型映射的临床和预后意义。
Arch Cardiovasc Dis. 2021 Mar;114(3):197-210. doi: 10.1016/j.acvd.2020.07.004. Epub 2021 Jan 8.
5
Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.应变成像技术评估射血分数保留心力衰竭患者的收缩功能障碍。
J Am Coll Cardiol. 2014 Feb 11;63(5):447-56. doi: 10.1016/j.jacc.2013.09.052. Epub 2013 Oct 30.
6
Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis.基于机器学习的无监督聚类分析对射血分数保留心力衰竭患者的表型分析。
Eur J Heart Fail. 2020 Jan;22(1):148-158. doi: 10.1002/ejhf.1621. Epub 2019 Oct 21.
7
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.射血分数保留的心力衰竭中的临床表型组:详细表型、预后及对螺内酯的反应
JACC Heart Fail. 2020 Mar;8(3):172-184. doi: 10.1016/j.jchf.2019.09.009. Epub 2020 Jan 8.
8
Exercise Stress Echocardiography-Based Phenotyping of Heart Failure With Preserved Ejection Fraction.基于运动负荷超声心动图的射血分数保留心力衰竭表型分析。
J Am Soc Echocardiogr. 2024 Aug;37(8):759-768. doi: 10.1016/j.echo.2024.05.003. Epub 2024 May 15.
9
Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction: Importance of Left Atrial Strain.射血分数保留的心力衰竭中心脏力学的预后效用及临床意义:左心房应变的重要性
Circ Cardiovasc Imaging. 2016 Mar;9(3). doi: 10.1161/CIRCIMAGING.115.003754.
10
Impaired Right Atrial Reserve Function in Heart Failure with Preserved Ejection Fraction.射血分数保留的心力衰竭患者右心房储备功能受损。
J Am Soc Echocardiogr. 2022 Aug;35(8):836-845. doi: 10.1016/j.echo.2022.03.006. Epub 2022 Mar 10.

本文引用的文献

1
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.恩格列净治疗射血分数保留的心力衰竭。
N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27.
2
Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial.吡非尼酮治疗射血分数保留的心力衰竭:一项随机 2 期试验。
Nat Med. 2021 Aug;27(8):1477-1482. doi: 10.1038/s41591-021-01452-0. Epub 2021 Aug 12.
3
Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial.达格列净治疗射血分数保留和轻度降低的心衰:DELIVER 试验的原理和设计。
Eur J Heart Fail. 2021 Jul;23(7):1217-1225. doi: 10.1002/ejhf.2249. Epub 2021 Jun 9.
4
Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial.左西孟旦改善 PH-HFpEF 患者血流动力学和运动耐量:随机安慰剂对照 HELP 试验结果。
JACC Heart Fail. 2021 May;9(5):360-370. doi: 10.1016/j.jchf.2021.01.015. Epub 2021 Apr 7.
5
Right Ventricular Global Longitudinal Strain and Outcomes in Heart Failure with Preserved Ejection Fraction.右心室整体纵向应变与射血分数保留心力衰竭患者的结局。
J Am Soc Echocardiogr. 2020 Aug;33(8):973-984.e2. doi: 10.1016/j.echo.2020.02.016. Epub 2020 May 7.
6
Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.射血分数保留的心力衰竭中的临床表型组:详细表型、预后及对螺内酯的反应
JACC Heart Fail. 2020 Mar;8(3):172-184. doi: 10.1016/j.jchf.2019.09.009. Epub 2020 Jan 8.
7
Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil.用于心力衰竭治疗的心肌肌球蛋白激活剂:聚焦于奥米卡替麦卡比。
Drugs Context. 2018 Apr 23;7:212518. doi: 10.7573/dic.212518. eCollection 2018.
8
Prognostic Factors After Index Hospitalization for Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者首次住院后的预后因素
Am J Cardiol. 2017 Jun 15;119(12):2017-2020. doi: 10.1016/j.amjcard.2017.03.032. Epub 2017 Mar 30.
9
Association of Chronic Kidney Disease With Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.射血分数保留的心力衰竭患者中慢性肾脏病与变时性功能不全的关联
Am J Cardiol. 2015 Oct 1;116(7):1093-100. doi: 10.1016/j.amjcard.2015.06.038. Epub 2015 Jul 21.
10
Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.射血分数保留的心力衰竭患者亚组特征及其对预后和治疗反应的潜在影响
Eur J Heart Fail. 2015 Sep;17(9):925-35. doi: 10.1002/ejhf.327. Epub 2015 Aug 6.

射血分数保留心力衰竭表型亚组中心脏力学和运动生理学的差异。

Differences in Cardiac Mechanics and Exercise Physiology Among Heart Failure With Preserved Ejection Fraction Phenomapping Subgroups.

机构信息

Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

出版信息

Am J Cardiol. 2023 Apr 15;193:102-110. doi: 10.1016/j.amjcard.2022.12.027. Epub 2023 Mar 7.

DOI:10.1016/j.amjcard.2022.12.027
PMID:36893548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10066831/
Abstract

Unsupervised machine learning (phenomapping) has been used successfully to identify novel subgroups (phenogroups) of heart failure with preserved ejection fraction (HFpEF). However, further investigation of pathophysiological differences between HFpEF phenogroups is necessary to help determine potential treatment options. We performed speckle-tracking echocardiography and cardiopulmonary exercise testing (CPET) in 301 and 150 patients with HFpEF, respectively, as part of a prospective phenomapping study (median age 65 [25th to 75th percentile 56 to 73] years, 39% Black individuals, 65% female). Linear regression was used to compare strain and CPET parameters by phenogroup. All indicies of cardiac mechanics except for left ventricular global circumferential strain worsened in a stepwise fashion from phenogroups 1 to 3 after adjustment for demographic and clinical factors. After further adjustment for conventional echocardiographic parameters, phenogroup 3 had the worst left ventricular global longitudinal, right ventricular free wall, and left atrial booster and reservoir strain. On CPET, phenogroup 2 had the lowest exercise time and absolute peak oxygen consumption (VO), driven primarily by obesity, whereas phenogroup 3 achieved the lowest workload, relative peak oxygen consumption (VO), and heart rate reserve on multivariable-adjusted analyses. In conclusion, HFpEF phenogroups identified by unsupervised machine learning analysis differ in the indicies of cardiac mechanics and exercise physiology.

摘要

无监督机器学习(表型映射)已成功用于识别射血分数保留的心力衰竭(HFpEF)的新型亚组(表型组)。然而,有必要进一步研究 HFpEF 表型组之间的病理生理差异,以帮助确定潜在的治疗选择。我们在一项前瞻性表型映射研究中分别对 301 名和 150 名 HFpEF 患者进行了斑点追踪超声心动图和心肺运动测试(CPET)(中位年龄 65 [25 至 75 百分位数 56 至 73] 岁,39%为黑人,65%为女性)。线性回归用于按表型组比较应变和 CPET 参数。在调整人口统计学和临床因素后,除左心室整体圆周应变外,所有心脏力学指标均按表型组 1 至 3 的顺序逐渐恶化。在进一步调整常规超声心动图参数后,表型组 3 的左心室整体纵向、右心室游离壁和左心房助推器和储液器应变最差。在 CPET 上,表型组 2 的运动时间和绝对峰值摄氧量(VO)最低,主要由肥胖引起,而表型组 3 在多变量调整分析中达到最低的工作量、相对峰值摄氧量(VO)和心率储备。总之,通过无监督机器学习分析确定的 HFpEF 表型组在心脏力学和运动生理学指标上存在差异。